ArticleJCO oncology practice2024

Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System.

Charles B Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.